Nicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly experienced patient adherence challenges for Parkinson’s Disease sufferers.

He also outlines the best strategy for success in increasing adherence in patients with PD, and highlights the combination of pharmacological and non-pharmacological approaches which works best. Nicolas then elaborates on how he facilitates communications with key stakeholders including patients’ organisations, caregivers and physicians. Furthermore, he explains how best to measure the effectiveness of professional and patient communication to increase the health of patients with PD. Finally, he projects how adherence strategies might evolve as new technologies enable different means and forms of communication with the patient population and other stakeholders.

[inlinead]